Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk

NCT05487950 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)

Interventions

DRUG: Rivaroxaban group

Sponsor

Assistance Publique - Hôpitaux de Paris